Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001934436 | SCV002214432 | uncertain significance | not provided | 2021-10-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with RINT1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys728*) in the RINT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 65 amino acid(s) of the RINT1 protein. |
Ambry Genetics | RCV004043057 | SCV003913651 | uncertain significance | not specified | 2023-02-27 | criteria provided, single submitter | clinical testing | The p.K728* variant (also known as c.2182A>T), located in coding exon 14 of the RINT1 gene, results from an A to T substitution at nucleotide position 2182. This changes the amino acid from a lysine to a stop codon within coding exon 14. This alteration is expected to result in premature protein truncation. However, the evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |